You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VELCADE

Showing 26 - 50 of 641
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Oct 18, 2021

Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Auto Stem Cell Transplant
  • Hackensack, New Jersey
    John Theurer Cancer Center @ Hackensack University Medical Cente
Dec 23, 2022

Multiple Myeloma Trial in Little Rock (M-VTD-PACE, TT3-LITE Regimen (L-TT3))

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences, Myeloma Institute f
Oct 4, 2021

Multiple Myeloma Trial in Worldwide (Velcade (Bortezomib), Thalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Velcade (Bortezomib)
  • +2 more
  • Graz, Austria
  • +80 more
Sep 21, 2021

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Multiple Myeloma Trial in Torino (Velcade, Melphalan, Prednisone)

Recruiting
  • Multiple Myeloma
  • Velcade
  • +5 more
  • Torino, TO, Italy
    Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
May 25, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Bortezomib, Metformin Hydrochloride,

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Jacksonville, Florida
  • +1 more
Jan 5, 2023

Multiple Myeloma Trial in Chicago, Milwaukee (Bortezomib, Isatuximab, Cyclophosphamide)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +1 more
Mar 14, 2022

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, Bortezomib)

Recruiting
  • Graft-versus-host Disease
  • New York, New York
    NYU Langone Health
Mar 24, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Everolimus, Rituximab, Bortezomib)

Terminated
Has Results
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Apr 22, 2021

Leukemia Trial in Washington (Bortezomib, Pravastatin)

Terminated
  • Leukemia
  • Washington, District of Columbia
    Children's National Medical Center
Apr 2, 2021

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Whittier, California
  • +113 more
Jan 17, 2023

Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Jan 17, 2023

Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)

Active, not recruiting
  • Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Dec 1, 2021

Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +8 more
Nov 30, 2022

Multiple Myeloma Trial in Germany, Greece (Daratumumab, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Berlin, Germany
  • +9 more
May 27, 2022

Breast Cancer Trial in Dallas (Bortezomib; pembrolizumab and cisplatin injections--bortezomib followed by pembro/cis)

Recruiting
  • Breast Cancer
  • Bortezomib; pembrolizumab and cisplatin injections--bortezomib followed by pembro/cis
  • Dallas, Texas
    Baylor University Medical Center, Baylor Charles A Sammons Cance
Oct 7, 2021

Multiple Myeloma Trial in Chicago (Carfilzomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jun 7, 2021

Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Multiple Myeloma Trial in Denmark, Estonia, Norway (Selinexor 20 MG Oral Tablet, Bortezomib Injection, Lenalidomide capsule)

Recruiting
  • Multiple Myeloma
  • Selinexor 20 MG Oral Tablet
  • +3 more
  • Aalborg, Denmark
  • +10 more
Apr 22, 2022

Lung Diseases, Interstitial, Systemic Sclerosis, Scleroderma Trial in Chicago (Bortezomib, Placebo, Mycophenolate mofetil)

Completed
Has Results
  • Lung Diseases, Interstitial
  • +2 more
  • Chicago, Illinois
    Northwestern University
Aug 2, 2021

Hematologic Malignancy Trial in United States (BBI608, Dexamethasone, Bortezomib)

Completed
  • Hematologic Malignancy
  • Denver, Colorado
  • +7 more
Apr 4, 2022

Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial in Shreveport (MTD of Velcade, Nipent and Rituxan

Withdrawn
  • Follicular Lymphoma
  • +2 more
  • MTD of Velcade, Nipent and Rituxan established in Part 1
  • Shreveport, Louisiana
    LSU - Shreveport Health Sciences Center, Feist-Weiller Cancer Ce
Aug 28, 2020